These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33130508)

  • 21. Current Status of Diagnostic Testing for SARS-CoV-2 Infection and Future Developments: A Review.
    Gao J; Quan L
    Med Sci Monit; 2020 Dec; 26():e928552. PubMed ID: 33332288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serial simultaneously self-swabbed samples from multiple sites show similarly decreasing SARS-CoV-2 loads in COVID-19 cases of differing clinical severity.
    Pan D; Sze S; Rogers B; Bron J; Bird PW; Holmes CW; Tang JW
    J Infect; 2020 Dec; 81(6):979-997. PubMed ID: 32956734
    [No Abstract]   [Full Text] [Related]  

  • 23. Diagnostics in the Time of Coronavirus Disease 2019 (COVID-19): Challenges and Opportunities.
    Zehnbauer B
    J Mol Diagn; 2021 Jan; 23(1):1-2. PubMed ID: 33349346
    [No Abstract]   [Full Text] [Related]  

  • 24. Are T cell repertoires useful as diagnostics for SARS- CoV- 2 infection?
    Harris T; Sauer K
    Expert Rev Mol Diagn; 2021 Feb; 21(2):137-139. PubMed ID: 33595410
    [No Abstract]   [Full Text] [Related]  

  • 25. [The pitfalls of preventive testing for SARS-CoV-2].
    Wismans LV; Fanoy EB; van Eijck CHJ; van der Eijk AA
    Ned Tijdschr Geneeskd; 2020 Dec; 165():. PubMed ID: 33332034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fully automated dried blood spot sample handling and extraction for serological testing of SARS-CoV-2 antibodies.
    Gaugler S; Sottas PE; Blum K; Luginbühl M
    Drug Test Anal; 2021 Jan; 13(1):223-226. PubMed ID: 33119946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of the SARS-CoV-2 humanized antibody with paper-based ELISA.
    Kasetsirikul S; Umer M; Soda N; Sreejith KR; Shiddiky MJA; Nguyen NT
    Analyst; 2020 Nov; 145(23):7680-7686. PubMed ID: 32975254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Summary of the Available Molecular Methods for Detection of SARS-CoV-2 during the Ongoing Pandemic.
    Arena F; Pollini S; Rossolini GM; Margaglione M
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-19.
    Flinck H; Rauhio A; Luukinen B; Lehtimäki T; Haapala AM; Seiskari T; Aittoniemi J
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115197. PubMed ID: 32977117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Healthcare worker infection with SARS-CoV-2 and test-based return to work.
    Shenoy ES; West LR; Hooper DC; Sheehan RR; Hashimoto D; Boukus ER; Aurora MN; McEvoy DS; Klompas M
    Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1464-1466. PubMed ID: 32843110
    [No Abstract]   [Full Text] [Related]  

  • 31. Assay requirements for COVID-19 testing: serology vs. rapid antigen tests.
    Prassas I; Fiala C; Diamandis EP
    Clin Chem Lab Med; 2021 Aug; 59(9):e348-e350. PubMed ID: 33730769
    [No Abstract]   [Full Text] [Related]  

  • 32. Special Focus Issue - COVID-19: bioanalytical considerations, contributions and lessons - part 2.
    Briscoe CJ; Barfield M
    Bioanalysis; 2021 Dec; 13(24):1779-1780. PubMed ID: 34806409
    [No Abstract]   [Full Text] [Related]  

  • 33. A high-throughput Anti-SARS-CoV-2 IgG testing platform for COVID-19.
    Du J; Chu E; Zhang D; Lu CM; Zhang A; Sha MY
    J Virol Methods; 2021 Jan; 287():114009. PubMed ID: 33152411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mass population screening for SARS-CoV-2 and false positives-why Liverpool shows we have a problem.
    Cook D
    BMJ; 2020 Dec; 371():m4954. PubMed ID: 33384318
    [No Abstract]   [Full Text] [Related]  

  • 35. The pharmacist's role in SARS-CoV-2 diagnostic testing.
    Goode JR; Page A; Burns A; Bernard S; Wheawill S; Gatewood SBS
    J Am Pharm Assoc (2003); 2020; 60(6):e19-e32. PubMed ID: 32883622
    [No Abstract]   [Full Text] [Related]  

  • 36. Simple Questionnaires to Improve Pooling Strategies for SARS-CoV-2 Laboratory Testing.
    Schneitler S; Jung P; Bub F; Alhussein F; Benthien S; Berger FK; Berkó-Göttel B; Eisenbeis J; Hahn D; Halfmann A; Last K; Linxweiler M; Lohse S; Papan C; Pfuhl T; Rissland J; Roth S; Schlotthauer U; Utzinger J; Smola S; Gärtner BC; Becker SL
    Ann Glob Health; 2020 Nov; 86(1):148. PubMed ID: 33262937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 Testing Tests Our Mettle.
    Hefferon KL; St Juliana JR; Miller HI
    Mo Med; 2020; 117(5):417-420. PubMed ID: 33311741
    [No Abstract]   [Full Text] [Related]  

  • 38. COVID-19 Laboratory Testing/CDC Guidelines.
    McFee DRB
    Dis Mon; 2020 Sep; 66(9):101067. PubMed ID: 32883517
    [No Abstract]   [Full Text] [Related]  

  • 39. One-house one-person testing: Strategical plan to limit COVID-19 spread in stage three in the developing world.
    Ali SME
    Infect Control Hosp Epidemiol; 2021 Jan; 42(1):117-118. PubMed ID: 32372726
    [No Abstract]   [Full Text] [Related]  

  • 40. Prospects of biotechnological production and adoption of COVID-19 serological assays in Nigeria.
    Abdullahi IN; Umar K; Omosigho PO
    Pan Afr Med J; 2020; 37(Suppl 1):31. PubMed ID: 33456655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.